StocksTelegraph
S&P 500NASDAQDOWRUSSELL
NASDAQ · BFRI·Healthcare

Biofrontera Inc. Stock Analysis & AI Score

Market Open
$1.16
Prev Close
Market Cap
Day Range
52W Range
P/E
EPS (TTM)
Volume
Avg —
Beta
52
ST Score
52.3/100B-

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees
CEO
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date
Website
Country
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

BFRI
52.3out of 100
Grade B-

Biofrontera Inc. (BFRI) holds an ST Score of 52.3 out of 100 (B-), with its strongest factor being Valuation (A) and its weakest Financial Strength (D-). Analysts rate BFRI Buy across 1 ratings.

Strongest
ValuationA
Weakest
Financial StrengthD-
All factor grades
  • ValuationA
  • GrowthA
  • MomentumB
  • ProfitabilityC+
  • Financial StrengthD-
  • Piotroski2/9
Score methodology
Press Releases

Contact

BFRI stock: frequently asked questions

What is BFRI's ST Score?

Biofrontera Inc. (BFRI) has an ST Score of 52.3 out of 100, an overall grade of B-. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is BFRI a buy, sell, or hold?

Wall Street's consensus rating on BFRI is Buy based on 1 analyst ratings. Our own ST Score grades it B- (52.3/100). This is data, not investment advice — always do your own research.

What is BFRI's valuation grade?

Biofrontera Inc. (BFRI) earns a valuation grade of A, measured against Medical - Pharmaceuticals peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is BFRI's growth grade?

Biofrontera Inc. (BFRI) earns a growth grade of A, measured against Medical - Pharmaceuticals peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is BFRI's profitability grade?

Biofrontera Inc. (BFRI) earns a profitability grade of C+, measured against Medical - Pharmaceuticals peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is BFRI's financial strength grade?

Biofrontera Inc. (BFRI) earns a financial strength grade of D-, measured against Medical - Pharmaceuticals peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is BFRI's Piotroski score?

Biofrontera Inc. (BFRI) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.